Linkou CGMHInternational Medicel CenterSite map

Update:2020/09/02

Primary appointment
Attending physician, Department of Radiation Oncology, Chang Gung Memorial Hospital – Linkou Medical Center
 
Specialty
Pediatric malignancies, brain tumors, lung cancer, and cancer related epidemiologic research
Education
September 2016-now, Ph.D, National Yang-Ming University, Institute of Public Health
September 2002-June 2009, M.D , Taipei Medical University, Taipei, Taiwan
Academic appointment &Employment record
2013 ~ 2014: Chief Resident, Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou branch, Taoyuan, Taiwan.
Aug 2010 ~ Aug 2014: Resident, Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou branch, Taoyuan, Taiwan.
July 2008 ~ May 2009: Internship: Taipei Medical University Hospital
Membership in Scientific and Medical Societies
American Society for Therapeutic Radiology and Oncology (ASTRO)
Europe Society for Radiotherapy & Oncology (ESTRO)
Taiwan Society for Therapeutic Radiology and Oncology Chinese Society for Medical Physics (TASTRO
Publication

(A) Journal Paper

  • Kao W-H, Kuo C-F, Chou I-J, et al. Prostate-selective α antagonists increase fracture risk in prostate cancer patients with and without a history of androgen deprivation therapy: a nationwide population-based study. Oncotarget. 2018;9(4):5263-5273. doi:10.18632/oncotarget.23828 (SCI)
  • Kao W-H, Hong J-H, See L-C, Yu H-P, Hsu J-T, Chou I-J, et al. Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan. Pharmacoepidemiology and Drug Safety [Internet]. 2017 Aug 16 [cited 2017 Oct 13]; (SCI)
  •  Lin, S. Y., Tsai, C. S., Chang, Y. C., Ng, K. K., Chang, T. C., Kao, W. H., Lai, C. H., Hong, J. H. The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up. International Journal of Radiation Oncology Biology Physics 2015; 92(3): 577-585 (SCI)
  • Kao, W. H., Shen, Y. L., Hong, J. H. What are the Potential Benefits of Using Proton Therapy in Taiwanese Cancer Patients? Biomedical Journal 2015; (ahead of print)
  • Kao, W. H., Hong, J. H., Chao, A. N. & Wang, J. J. Hypofractionated Stereotactic Photon Radiotherapy for Choroidal Melanoma. Therapeut Radiol Oncol 2014; 21(0): 1-10

(B) Conference Paper

  • Kao, W. H., Chiang, Y. J., Hong, J. H., Wang, C. C. Birth Outcomes in Childbearing Age Female Cancer Survivors: A Nationwide Population-based Study. Poster presented at Europe Society for Radiation Oncology (ESTRO) 36th Annual Meeting, Vienna, May 05-07, 2017
  • Kao, W. H., Lin, S.Y., Hong, J. H. & Tsai, J. S. A long-term Follow-up for a Prospective Randomized Trial Using Pretreatment FDG-PET in the Management of Cervical Cancer with Enlarged Pelvic Lymph Nodes on MRI image. Poster presented at the 18th Taiwan Joint Cancer Conference (TJCC), July 13~14, 2013
  • Kao, W. H. & Wang, C. C. Whole Brain Radiotherapy with Simultaneously Integrated Boost for Patients with Multiple Brain Metastases by VMAT. Poster presented at American Society for Radiation Oncology (ASTRO) 55th Annual Meeting, Atlanta, Sept. 22-25, 2013